Letter of Intent signed with a Leipzig clinic for animal testing

We have signed a Letter of Intent with a leading research clinic in Leipzig, Germany, to host the first in-vivo animal study of the ICP Monitor implantable sensing interface.

The study will characterise long-term signal fidelity, biocompatibility of the encapsulation, and stability of the inductive telemetry link under realistic physiological conditions.

Leipzig's neurosurgical research ecosystem gives us access to rigorous pre-clinical infrastructure and expert oversight — a critical step on the path to first-in-human evaluation.